Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $958000.0.

  • Enanta Pharmaceuticals' Amortizatization of Intangibles fell 2029.95% to $958000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$503000.0, marking a year-over-year decrease of 14420.04%. This contributed to the annual value of -$503000.0 for FY2025, which is 14420.04% down from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Amortizatization of Intangibles is $958000.0, which was down 2029.95% from -$13000.0 recorded in Q2 2025.
  • Enanta Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $1.4 million during Q2 2023, with a 5-year trough of -$816000.0 in Q1 2025.
  • In the last 5 years, Enanta Pharmaceuticals' Amortizatization of Intangibles had a median value of -$53000.0 in 2022 and averaged $33421.1.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first skyrocketed by 177812.5% in 2024, then crashed by 316400.0% in 2025.
  • Quarter analysis of 5 years shows Enanta Pharmaceuticals' Amortizatization of Intangibles stood at -$546000.0 in 2021, then surged by 162.09% to $339000.0 in 2022, then plummeted by 180.83% to -$274000.0 in 2023, then plummeted by 130.66% to -$632000.0 in 2024, then soared by 251.58% to $958000.0 in 2025.
  • Its last three reported values are $958000.0 in Q3 2025, -$13000.0 for Q2 2025, and -$816000.0 during Q1 2025.